A detailed history of Quantinno Capital Management LP transactions in Zoetis Inc. stock. As of the latest transaction made, Quantinno Capital Management LP holds 61,059 shares of ZTS stock, worth $10.1 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
61,059
Previous 36,860 65.65%
Holding current value
$10.1 Million
Previous $6.39 Million 86.68%
% of portfolio
0.16%
Previous 0.12%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$172.58 - $196.48 $4.18 Million - $4.75 Million
24,199 Added 65.65%
61,059 $11.9 Million
Q2 2024

Aug 14, 2024

SELL
$145.54 - $178.83 $2 Million - $2.45 Million
-13,716 Reduced 27.12%
36,860 $6.39 Million
Q1 2024

May 14, 2024

BUY
$165.67 - $199.94 $1.45 Million - $1.75 Million
8,769 Added 20.97%
50,576 $8.56 Million
Q4 2023

Feb 14, 2024

BUY
$151.44 - $200.09 $745,539 - $985,043
4,923 Added 13.35%
41,807 $8.25 Million
Q3 2023

Nov 14, 2023

BUY
$167.14 - $192.77 $3.08 Million - $3.56 Million
18,453 Added 100.12%
36,884 $6.42 Million
Q2 2023

Aug 04, 2023

BUY
$160.94 - $186.23 $76,446 - $88,459
475 Added 2.65%
18,431 $3.17 Million
Q1 2023

May 03, 2023

BUY
$145.48 - $175.02 $299,252 - $360,016
2,057 Added 12.94%
17,956 $2.99 Million
Q4 2022

Feb 13, 2023

BUY
$131.14 - $157.47 $554,197 - $665,468
4,226 Added 36.2%
15,899 $2.33 Million
Q3 2022

Nov 07, 2022

BUY
$148.29 - $182.55 $177,354 - $218,329
1,196 Added 11.42%
11,673 $1.73 Million
Q2 2022

Aug 15, 2022

BUY
$155.97 - $200.09 $35,093 - $45,020
225 Added 2.19%
10,477 $1.8 Million
Q1 2022

May 12, 2022

SELL
$181.39 - $234.03 $80,899 - $104,377
-446 Reduced 4.17%
10,252 $1.93 Million
Q4 2021

Feb 14, 2022

BUY
$193.69 - $247.03 $2.07 Million - $2.64 Million
10,698 New
10,698 $2.61 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.1B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Quantinno Capital Management LP Portfolio

Follow Quantinno Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantinno Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantinno Capital Management LP with notifications on news.